BiotechTV

•

Channel • 5 Shows

Life Sciences

Life Sciences

Updated 5 May
Life Sciences

Life Sciences

Updated Fortnightly
Life Sciences

Life Sciences

Updated 2 Feb
Life Sciences

Life Sciences

Updated 23 Apr
Life Sciences

Life Sciences

Updated 5 Mar

4 MAY

Episode 39: SV Health Investors' Kate Bingham

Kate Bingham describes her early life and a serendipitous opportunity to work at Vertex in the early 1990's. She then discusses joining SV Health and describes its investment approaches, the Dementia Discovery Fund, being on the UK's Vaccine Taskforce during Covid, and more.

4 May

•

1hr 13min
5 MAY

London based Cytospire Therapeutics has announced an $83M series A financing to develop first-in-class pan-gamma delta T-cell engagers - the lead program is an EGFR targeting solid tumors

Co-Founder & CEO Natalie Mount discusses the raise, and explains why she believes gamma delta T-cell engagers have advantages over CD3s. After presenting preclinical data at the recent AACR annual meeting, the lead EGFR program is preparing to go into the clinic.

5 May

•

17 min
11 JAN

Episode 32: ARCH Venture Partners' Bob Nelsen

While describing his early life in Washington and formative years at the University of Chicago that led to the founding of ARCH, he shares his thoughts on leadership, risk taking, changes he thinks are need to keep the United States competitive in life sciences, and his belief in AI's promise to transform our industry.

11 Jan

•

1hr 15min
20 APR

Episode 38: Deerfield Management's Jason Fuller

He discusses his education and joining the Langer Lab at MIT, early experiences in venture, including at Third Rock and NEA, and gaining operational experience at Jounce before joining Deerfield. Plus, areas that interest him today and how he thinks about AI.

20 Apr

•

1hr 6min
12 FEB

Analyst Thursdays: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened

He discusses upcoming readouts for IDEAYA Biosciences, Ocular Therapeutix (how it might affect EyePoint), and Palvella Therapeutics. Plus, his take on the recent Corvus atopic dermatitis data.

12 Feb

•

19 min
23 MAR

Episode 37: SR One's Simeon George

Simeon George discusses his early days at SR One while it was part of GSK, and the transition to making the firm independent in 2020. Plus, the importance of peer-to-peer collaboration, and his how he thinks about investing in different indications and modalities.

23 Mar

•

1hr 6min
18/11/2024

Episode 6: Omega Funds' Otello Stampacchia

He describes his career path, including time in the lab and doing quant work at Goldman Sachs. Plus, what he has learned about VC investing and biotech over time, and how Omega Funds is able to successfully invest in various stages and rounds of companies.

18/11/2024

•

1hr 16min
9 FEB

Episode 34: General Atlantic's Brett Zbar

Brett Zbar describes his early career, including working at Aisling Capital and Foresight Capital, and now managing the healthcare strategy at General Atlantic. He describes how he sees the difference between private equity and venture capital, and discusses which themes in biotech and healthcare appeal to him today.

9 Feb

•

1hr 7min
17 APR

Is this analyst the world's biggest bear on the weight loss space? After downgrading Lilly to a sell rating, HSBC's Rajesh Kumar discusses why he thinks pricing factors are being under-appreciated

Plus, discussions on key trial readouts outside of obesity: eplontersen, Lp(a), oral IL-23, and milvexian.

17 Apr

•

26 min
23 FEB

Episode 35: INITIATE Ventures' Jessica Owens

Jessica Owens discusses the many experiences she has had in her career, including working on the venture side at Kleiner Perkins and Versant Ventures and on the operating side at Genomic Health and Grail. She highlights the value of VCs being able to understand how operators like CEOs think, and describes the type of investing INITIATE focuses on.

23 Feb

•

1hr 9min

BiotechTV covers the biotechnology sector through news, stories, podcasts, and educational videos.

Website

BiotechTV

Top Shows

Episode 39: SV Health Investors' Kate Bingham

London based Cytospire Therapeutics has announced an $83M series A financing to develop first-in-class pan-gamma delta T-cell engagers - the lead program is an EGFR targeting solid tumors

Episode 32: ARCH Venture Partners' Bob Nelsen

Episode 38: Deerfield Management's Jason Fuller

Analyst Thursdays: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened

Episode 37: SR One's Simeon George

Episode 6: Omega Funds' Otello Stampacchia

Episode 34: General Atlantic's Brett Zbar

Is this analyst the world's biggest bear on the weight loss space? After downgrading Lilly to a sell rating, HSBC's Rajesh Kumar discusses why he thinks pricing factors are being under-appreciated

Episode 35: INITIATE Ventures' Jessica Owens

About

BiotechTV

Top Shows

Top Episodes

About